Showing results (131-140 of 372) with videos related to
Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Prognostic significance of molecular markers and extent of resection in primary glioblastoma patientsJörg Felsberg, Marion Rapp, Simon Loeser, et al.International Journal of Cancer|December 6, 2011
Predictive impact of MGMT promoter methylation in glioblastoma of the elderlyGuido Reifenberger, Bettina Hentschel, Jörg Felsberg, et al.Scientific Reports|September 10, 2021
Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cellsRikke H Dahlrot, Julie A Bangsø, Jeanette K Petersen, et al.Brain Pathology (Zurich, Switzerland)|June 15, 2004
Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survivalJörg Felsberg, Angelika Erkwoh, Michael C Sabel, et al.Journal of Neuro-Oncology|March 11, 2010
Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I studyDominik Cordier, Flavio Forrer, Stefan Kneifel, et al.Cancer|January 11, 2005
Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapyDaniel Beutler, Pierino Avoledo, Jean-Claude Reubi, et al.International Journal of Cancer|March 22, 2006
Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profilingBjoern Tews, Joerg Felsberg, Christian Hartmann, et al.International Journal of Cancer|August 11, 2007
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomasEva M Grasbon-Frodl, Friedrich Wilhelm Kreth, Michael Ruiter, et al.International Journal of Cancer|February 8, 2007
Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumorsDetlef Trost, Marion Ehrler, Rolf Fimmers, et al.Nature Reviews. Neurology|June 11, 2014
MGMT testing--the challenges for biomarker-based glioma treatmentWolfgang Wick, Michael Weller, Martin van den Bent, et al.Pageof 38